Ultrasound Helmet Offers Innovative Treatments for Neurological Conditions
Recent findings suggest that an ultrasound “helmet” may provide new, non-invasive options for treating various neurological issues. This innovative device can focus on brain areas that are incredibly small, up to 1,000 times more specific than current ultrasound technology allows.
It could potentially transform how we approach disorders like Parkinson’s disease, and might also offer new insights for managing conditions such as depression, Tourette syndrome, chronic pain, Alzheimer’s, and even addiction.
In contrast to deep brain stimulation (DBS), which requires surgery to implant electrodes directly into the brain, this ultrasound method utilizes mechanical pulses that are directed into the brain without the need for invasive procedures. However, getting precise control over these ultrasound waves has been a challenge – until now.
A study featured in Nature Communications introduces a groundbreaking technique that can target areas of the brain 30 times smaller than what previous ultrasound devices could manage.
“It’s essentially a helmet with 256 ultrasound sources, designed to fit inside an MRI scanner,” explained Ioana Grigoras from Oxford University, who is both a study author and participant. “At first, it feels a bit bulky and confining, but soon you get used to it.”
Currently, DBS methods for Parkinson’s require rigid metal frames that are screwed into the skull, which isn’t the most comfortable option for patients.
In this study, researchers tested the helmet on seven volunteers, targeting a small area—the size of a grain of rice—within the lateral geniculate nucleus (LGN), crucial for how the eyes send visual information to the brain.
“The accuracy with which the waves hit their target was remarkable,” noted senior author Prof. Charlotte Stagg from Oxford. “This achievement is significant, and no one has accomplished something like this before.”
Follow-up tests showed positive changes in the visual cortex as a result of modulating the LGN. “If we could target a motor control area for Parkinson’s patients, we might see a reduction in their tremors,” she mentioned.
Neuroscience expert Elsa Fouragnan from Plymouth University commented that this proof-of-concept is a key milestone in neuroscience, paving the way for future clinical applications. She extended her congratulations to the research team for their significant accomplishment.
This project has spanned over a decade, with collaboration between teams from University College London and Oxford to develop and integrate the helmet with the MRI scanner.
Stagg shared a personal touch, stating that when the project began, she was pregnant with her now 12-year-old daughter. “We hope to see clinical applications before she heads off to university,” she added.
The research team is already working on testing the device on brain areas related to Parkinson’s, schizophrenia, stroke recovery, and more.
The helmet is truly unique. The core group involved in its development, including UCL academics Elly Martin and Brad Treeby, have focused on ensuring patient comfort and broad applicability.
Treeby expressed his commitment, stating, “I started a company to specifically concentrate on helmet development.” While it currently needs an MRI scan for navigation, the integration of AI could eventually allow it to operate independently, making it accessible for at-home use.
Martin emphasized that additional research is essential, saying, “Our ultimate goal is to refine this into a practical clinical tool, one that could supplement or even replace invasive brain implants in the future.”
